APA (7th ed.) Citation

Ito, T., Kuriyama, N., Kozuka, Y., Komatsubara, H., Ichikawa, K., Noguchi, D., . . . Isaji, S. (2020). High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection. BMC.

Chicago Style (17th ed.) Citation

Ito, Takahiro, et al. High Tumor Budding Is a Strong Predictor of Poor Prognosis in the Resected Perihilar Cholangiocarcinoma Patients Regardless of Neoadjuvant Therapy, Showing Survival Similar to Those Without Resection. BMC, 2020.

MLA (8th ed.) Citation

Ito, Takahiro, et al. High Tumor Budding Is a Strong Predictor of Poor Prognosis in the Resected Perihilar Cholangiocarcinoma Patients Regardless of Neoadjuvant Therapy, Showing Survival Similar to Those Without Resection. BMC, 2020.

Warning: These citations may not always be 100% accurate.